HUP0002322A2 - Multivalens vakcinakészítmény kevert hordozóval - Google Patents

Multivalens vakcinakészítmény kevert hordozóval

Info

Publication number
HUP0002322A2
HUP0002322A2 HU0002322A HUP0002322A HUP0002322A2 HU P0002322 A2 HUP0002322 A2 HU P0002322A2 HU 0002322 A HU0002322 A HU 0002322A HU P0002322 A HUP0002322 A HU P0002322A HU P0002322 A2 HUP0002322 A2 HU P0002322A2
Authority
HU
Hungary
Prior art keywords
vaccine composition
multivalent vaccine
mixed carrier
polysaccharides
carrier
Prior art date
Application number
HU0002322A
Other languages
English (en)
Inventor
Odile Leroy
Original Assignee
Pasteur Merieux Serums & Vaccins
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9507086&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0002322(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pasteur Merieux Serums & Vaccins filed Critical Pasteur Merieux Serums & Vaccins
Publication of HUP0002322A2 publication Critical patent/HUP0002322A2/hu
Publication of HUP0002322A3 publication Critical patent/HUP0002322A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A találmány gyógyászati készítményekre vonatkozik, amelyek patogénágensek, például baktériumok okozta fertőzések megelőzésére vagykezelésére alkalmazhatók, és amelyek immunogénként egy vagy több, egyvagy több patogén ágensből származó poliszacharidot tartalmaznak. Akészítményben a poliszacharidok konjugátum formájában vannak jelen,hordozóproteinhez kapcsoltan. A készítmény legalább két típusúkonjugátumot tartalmaz, amelyek legalább hordozóproteinjeikvonatkozásában különbözőek. Ó
HU0002322A 1997-05-14 1998-05-14 Multivalent vaccine composition with mixed carrier HUP0002322A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9706210A FR2763244B1 (fr) 1997-05-14 1997-05-14 Composition vaccinale multivalente a porteur mixte

Publications (2)

Publication Number Publication Date
HUP0002322A2 true HUP0002322A2 (hu) 2000-11-28
HUP0002322A3 HUP0002322A3 (en) 2001-12-28

Family

ID=9507086

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002322A HUP0002322A3 (en) 1997-05-14 1998-05-14 Multivalent vaccine composition with mixed carrier

Country Status (20)

Country Link
US (2) US7862823B1 (hu)
EP (1) EP0983087B1 (hu)
JP (1) JP2001525815A (hu)
KR (1) KR100709628B1 (hu)
CN (1) CN1154509C (hu)
AT (1) ATE279942T1 (hu)
AU (1) AU748716B2 (hu)
BR (1) BR9808772A (hu)
CA (1) CA2289009C (hu)
CZ (1) CZ295272B6 (hu)
DE (1) DE69827127T2 (hu)
ES (1) ES2227840T3 (hu)
FR (1) FR2763244B1 (hu)
HU (1) HUP0002322A3 (hu)
IL (3) IL132669A0 (hu)
NO (1) NO320415B1 (hu)
NZ (1) NZ500738A (hu)
PL (1) PL189653B1 (hu)
PT (1) PT983087E (hu)
WO (1) WO1998051339A1 (hu)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034792A1 (en) * 1999-03-11 2000-09-13 Pasteur Merieux Serums Et Vaccins Intranasal delivery of pneumococcal polysaccharide vaccines
CN100339130C (zh) * 1999-03-19 2007-09-26 史密丝克莱恩比彻姆生物有限公司 疫苗
GB9909077D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
FR2806304B1 (fr) * 2000-03-17 2002-05-10 Aventis Pasteur Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0130215D0 (en) * 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine
FR2850106B1 (fr) 2003-01-17 2005-02-25 Aventis Pasteur Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
GB0500787D0 (en) 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
GB0409745D0 (en) 2004-04-30 2004-06-09 Chiron Srl Compositions including unconjugated carrier proteins
BRPI0510315A (pt) 2004-04-30 2007-10-16 Chiron Srl integração de vacinação com conjugado meningocócico
GB0419846D0 (en) * 2004-09-07 2004-10-13 Chiron Srl Vaccine adjuvants for saccharides
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP2425856A1 (en) 2005-04-08 2012-03-07 Wyeth LLC Multivalent pneumococcal polysaccharide-protein conjugate composition
HUE045482T2 (hu) 2005-06-27 2019-12-30 Glaxosmithkline Biologicals Sa Immunogén készítmény
JP5135220B2 (ja) 2005-09-01 2013-02-06 ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー 血清群ｃ髄膜炎菌を含む複数ワクチン接種
MY150719A (en) 2005-12-22 2014-02-28 Glaxosmithkline Biolog Sa Pneumococcal polysaccharide conjugate vaccine
TW200806315A (en) 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
US8808707B1 (en) 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
AU2008248640A1 (en) 2007-05-02 2008-11-13 Glaxosmithkline Biologicals S.A. Vaccine
EP2170391B1 (en) * 2007-06-20 2017-01-18 Pfizer Ireland Pharmaceuticals Modified polysaccharides for conjugate vaccines
US9610340B2 (en) 2007-06-26 2017-04-04 Glaxosmithkline Biologicals, S.A. Vaccine comprising Streptococcus pneumoniae capsular polysaccharide conjugates
US20130071422A1 (en) 2010-03-18 2013-03-21 Michele Pallaoro Adjuvanted vaccines for serogroup b meningococcus
BR112013005049A2 (pt) 2010-09-02 2016-05-31 Sanofi Pasteur estabilizador para a preparação de uma composição vacina da pólio seca injetável
GB201101665D0 (en) 2011-01-31 2011-03-16 Novartis Ag Immunogenic compositions
HUE040914T4 (hu) * 2012-01-30 2019-05-28 Serum Institute Of India Pvt Ltd Immunogén készítmény
ES2773954T3 (es) 2012-10-03 2020-07-15 Glaxosmithkline Biologicals Sa Composición inmunogénica
WO2016012385A1 (en) 2014-07-21 2016-01-28 Sanofi Pasteur Vaccine composition comprising ipv and cyclodextrins
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
CN105695497B (zh) 2014-11-27 2019-09-24 中国人民解放军军事医学科学院生物工程研究所 一种细菌多糖修饰的重组融合蛋白的制备方法及其应用
AU2016285017B2 (en) 2015-06-23 2022-03-03 Biological E Limited Multivalent pneumococcal conjugate vaccine
WO2018027126A1 (en) * 2016-08-05 2018-02-08 Sanofi Pasteur, Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
CA3031797A1 (en) * 2016-08-05 2018-02-08 Sanofi Pasteur, Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
CA3037056A1 (en) 2016-09-30 2018-04-05 Biological E Limited Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
CA3048981A1 (en) 2016-12-30 2018-07-05 Sutrovax, Inc. Polypeptide-antigen conjugates with non-natural amino acids
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
WO2018227177A1 (en) 2017-06-10 2018-12-13 Inventprise, Llc Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
US10729763B2 (en) 2017-06-10 2020-08-04 Inventprise, Llc Mixtures of polysaccharide-protein pegylated compounds
CA3087572A1 (en) * 2018-02-05 2019-08-08 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
JP6950099B2 (ja) 2018-02-05 2021-10-13 サノフィ パスツール インコーポレイティッド 多価肺炎球菌多糖体−タンパク質複合体組成物
JP2021522213A (ja) 2018-04-18 2021-08-30 エスケー バイオサイエンス カンパニー リミテッド ストレプトコッカス・ニューモニエ莢膜多糖類及びその免疫原性接合体
JP7399934B2 (ja) 2018-07-04 2023-12-18 バックスサイト・インコーポレイテッド 免疫原性複合体の改良
WO2020010016A1 (en) 2018-07-04 2020-01-09 Sutrovax, Inc. Self-adjuvanted immunogenic conjugates
WO2023200704A1 (en) 2022-04-11 2023-10-19 Sanofi Pasteur Inc. Protein-saccharide conjugation with sodium cyanoborohydride

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5639022A (en) * 1979-09-05 1981-04-14 Hayashibara Biochem Lab Inc Preparation of vaccine
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
CN100339130C (zh) 1999-03-19 2007-09-26 史密丝克莱恩比彻姆生物有限公司 疫苗
GB0130215D0 (en) 2001-12-18 2002-02-06 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
NO995349L (no) 1999-11-02
ES2227840T3 (es) 2005-04-01
CN1255861A (zh) 2000-06-07
IL132669A (en) 2010-11-30
PL189653B1 (pl) 2005-09-30
US8029798B2 (en) 2011-10-04
AU7773098A (en) 1998-12-08
IL132669A0 (en) 2001-03-19
DE69827127D1 (de) 2004-11-25
FR2763244A1 (fr) 1998-11-20
HUP0002322A3 (en) 2001-12-28
IL183296A0 (en) 2007-09-20
KR20010012477A (ko) 2001-02-15
DE69827127T2 (de) 2005-03-24
PT983087E (pt) 2005-01-31
ATE279942T1 (de) 2004-11-15
JP2001525815A (ja) 2001-12-11
NO320415B1 (no) 2005-12-05
CZ295272B6 (cs) 2005-06-15
PL336704A1 (en) 2000-07-03
CA2289009A1 (fr) 1998-11-19
US20110117123A1 (en) 2011-05-19
FR2763244B1 (fr) 2003-08-01
BR9808772A (pt) 2000-09-05
NZ500738A (en) 2002-03-28
CN1154509C (zh) 2004-06-23
EP0983087B1 (fr) 2004-10-20
WO1998051339A1 (fr) 1998-11-19
CZ9904021A3 (en) 2001-06-13
EP0983087A1 (fr) 2000-03-08
US7862823B1 (en) 2011-01-04
CA2289009C (fr) 2011-04-26
AU748716B2 (en) 2002-06-13
KR100709628B1 (ko) 2007-04-19
NO995349D0 (no) 1999-11-02

Similar Documents

Publication Publication Date Title
HUP0002322A2 (hu) Multivalens vakcinakészítmény kevert hordozóval
HUP0101564A2 (hu) Epotilon készítmények
BR9910089A (pt) Composições e antìgenos de neisseria meningitidis
BR0113822A (pt) Vacina
MX349481B (es) Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
MXPA02006029A (es) Lipopeptidos novedosos como agentes antibacterianos.
CY1109202T1 (el) Συνθεσεις που περιεχουν αντιγονα απο τους οροτυπους b και c της neisseria meningitidis οπως και επιπλεον αντιγονα απο τον οροτυπο α
MXPA02006030A (es) Lipopeptidos como agentes antibacterianos.
ATE276758T1 (de) Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
BR0010721A (pt) Composições de neisserias combinadas
DE69940769D1 (de) Orale flüssige zusammensetzungen
DK1157037T3 (da) GCSF-konjugater
NO975547L (no) Vaksiner med modifiserte meningokokk/polysakkarid-konjugater
BR0001468A (pt) ácidos dioxiciclopentil hidroxânicos
EP1423137A4 (en) STEREO-ISOMERS OF LIPOPEPTIDE, METHODS OF PREPARATION AND USEFUL INTERMEDIATES
PT1057828E (pt) Suspensoes de trovafloxacina para administracao oral
DE69921486D1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren
NO20010940D0 (no) TAN-1057 derivater
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: SANOFI PASTEUR, FR

Free format text: FORMER OWNER(S): PASTEUR MERIEUX SERUMS & VACCINS, FR; AVENTIS PASTEUR, FR

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished